Greater efforts by healthcare providers to build trusting relationships with people with HIV and hepatitis C, together with a greater focus on overcoming concerns about treatment side effects, are likely to be needed to encourage people reluctant to start treatment to begin taking hepatitis C medication, according to the findings of a US interview study.
Read the full story at infohep.
Source : infohep
Related HIV and Co-Infections News
-
ACTG launches landmark study evaluating treatments for depressive disorders with or without mild neurocognitive disorder among people living with HIV
-
Florida International University: HIV disrupts lung “clock,” raising COPD and emphysema risk
-
ESCMID: HIV treatment reduces accelerated biological aging by nearly four years, landmark study shows
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.